Navigation Links
Abbott to Present at Bear Stearns Healthcare Conference
Date:9/4/2007

ABBOTT PARK, Ill., Sept. 4 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the Bear Stearns 20th Annual Healthcare Conference on Tuesday, Sept. 11, 2007. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at 8:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com. An archived edition of the presentation will be available later that day.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Pharmacia may take 51.5 percent Abbott stake
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. Abbott’s Laboratories R&D Capabilities Questione
4. Abbott Receives CE Mark Certification
5. Abbott to Subsidize Price of HIV Drug
6. Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
7. Abbotts Humira(r) (Adalimumab) Gets Approval by EU for Crohns Disease Treatment
8. Tony Abbott Confident Of Australias Vote For Performance Not Promise
9. Abbotts RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
10. AIDS Foundation Lauds Brazil for Negotiating Price Cut on Abbotts Kaletra
11. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... the development of products that help survivors of stroke and ... the publication of an interview with the inventors of their ... Physical Therapy and Rehab Medicine, vol. 20, issue 20, page ... ... (PRWEB) December 16, 2009 -- In the ...
(Date:12/16/2009)... Hair Shake in all of the Florida Whole Foods store. ... ... Larry Shapiro, hair transplant and hair loss physician , is pleased ... Hair Whey Protein Shake. Dr. Shapiro developed the all natural growth-hormone ... programs, working out and muscle building., , , , ,The Whole Foods ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate ... and Affordable Care Act that would have helped ... the safe and legal importation of lower priced ... AARP and sponsored by Senators Dorgan, Snowe, McCain, ... helped to bring down the skyrocketing costs of ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security ... its PA-4000 Series next-generation firewalls for accurate threat ... visibility and control over applications such as peer-to-peer ... national university with eight facilities on five campuses. ... a number of academic schools and institutions throughout ...
(Date:12/15/2009)... Vitech Systems Group, a leading provider of Benefits ... today that it has completed a major V3 ... Guild-Producers Pension & Health Plans (SAG-PH). ,, The ... SAG-PH call center personnel in Burbank, Ventura and ... V3 Benefits Administration System which consolidated data from ...
Breaking Medicine News(10 mins):Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2
... CITY, Calif., April 22 Cardica, Inc.,(Nasdaq: CRDC ... for,its fiscal third quarter ended March 31, 2008, on ... company,s management will host a,conference call at 4:30 p.m. ... update on the company,s business., Conference Call Details, ...
... Symposium Seoul, Korea - ... June 20, 2008, ... peer-reviewed journal STEM CELLS(R), announces that the,annual STEM CELLS(R) Young Investigator Award, ... 20, 2008 in,Seoul, Korea. The US$10,000 award will be presented to a ...
... getting drugs they need, but sickest still going without, study ... Part D benefit has resulted in some improvements for seniors ... A new report finds that Medicare beneficiaries are less likely ... medicine, but the sickest patients are still skipping meds due ...
... South Carolina and Illinois are Runners-Up, WASHINGTON, April ... when a friend had trouble finding an internship,was today ... turning his,idea into a multi-million dollar Web site., ... Small Business,Administration,s celebration of National Small Business Week 2008., ...
... Media is First in a,Series of Educational Publications ... April 22 The Grocery,Manufacturers Association (GMA) today ... the Media, the first in a series of ... accurate,information and resources for journalists, health professionals and,policymakers., ...
... unclear, but nursing home study says risk greatest week after ... Nursing home patients who take antipsychotic drugs are 60 percent ... those who don,t take the drugs, a new study shows. ... patients start taking the medications and gradually decreases, say Dutch ...
Other Medicine News:Health News:Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008 2Health News:Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award 2Health News:Medicare Prescription Drug Benefit Shows Mixed Results 2Health News:Medicare Prescription Drug Benefit Shows Mixed Results 3Health News:Online Job Search Company from Virginia is National Small Business of the Year 2Health News:Online Job Search Company from Virginia is National Small Business of the Year 3Health News:Online Job Search Company from Virginia is National Small Business of the Year 4Health News:Grocery Manufacturers Association Releases Science Policy Paper on Bisphenol A 2Health News:Antipsychotic Drugs Linked to Pneumonia in Elderly 2
(Date:12/16/2009)... MOUNTAIN VIEW, Calif., Dec. 16 ChemoCentryx, ... patients in a Phase 2 clinical trial of ... to specifically target the CCR1 chemokine receptor for ... CCX354 is a highly potent and selective antagonist ... recruitment of immune cells, such as monocytes and ...
(Date:12/15/2009)... Dec. 15 Warner Chilcott plc (Nasdaq: ... Warner Chilcott Corporation (the "Company") has commenced a ... to the conditions set forth in the Company,s ... December 15, 2009 (the "Offer to Purchase"), for ... subordinated notes due 2015 (the "Notes"). ,, The ...
(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global leader ... patient care, reiterated its commitment to provide blood centers ... products, despite a new lawsuit filed yesterday against Fenwal ... system, introduced in 2003, is an advanced medical instrument ... from a single donor in about 30 minutes. ...
Breaking Medicine Technology:ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences 56235 1Giving Swine Flu Drug by IV Could Save Lives 56232 1Giving Swine Flu Drug by IV Could Save Lives 56232 2Giving Swine Flu Drug by IV Could Save Lives 56232 3Planned Parenthood Stresses Importance of Regular Checkups During Gynecologic Cancer Awareness Month 56229 1Planned Parenthood Stresses Importance of Regular Checkups During Gynecologic Cancer Awareness Month 56229 2
... (MARKET WIRE) -- July 06, ... <a target="_blank" href=,'http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB"%3EDORB'>,http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB">DORB ),("DOR" or ... the European Patent,Office has granted ... with claims related to,oral vaccination ...
... 2007 /PRNewswire-FirstCall/ --,Genzyme Corp. announced top-line data today ... to assess the safety and efficacy of,tolevamer liquid, ... difficile associated diarrhea,(CDAD). The second Phase 3 study ... expected later this year. , In this first ...
Other Medicine Technology:DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: